| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T2048 |
Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem |
1,744 |
615 |
$7.24M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,573 |
2,778 |
$5.35M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
35,179 |
29,859 |
$5.04M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
9,904 |
4,296 |
$4.71M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
40,535 |
32,993 |
$4.14M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
6,260 |
4,932 |
$4.10M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
28,696 |
24,134 |
$4.07M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,934 |
20,671 |
$3.31M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
42,830 |
29,424 |
$2.74M |
| 43249 |
|
1,335 |
941 |
$2.66M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
15,664 |
4,582 |
$2.18M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
34,823 |
28,015 |
$2.04M |
| 71045 |
Radiologic examination, chest; single view |
15,758 |
12,654 |
$2.00M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
14,689 |
4,352 |
$1.89M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,975 |
3,823 |
$1.43M |
| 71046 |
Radiologic examination, chest; 2 views |
10,128 |
8,690 |
$1.00M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
27,578 |
22,727 |
$904K |
| 59025 |
Fetal non-stress test |
3,505 |
2,625 |
$843K |
| 64483 |
|
892 |
756 |
$754K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,300 |
1,896 |
$679K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,428 |
3,901 |
$603K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
718 |
581 |
$591K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,833 |
1,465 |
$463K |
| 64635 |
|
265 |
198 |
$440K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,408 |
5,797 |
$425K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
105,930 |
84,210 |
$417K |
| 64493 |
|
429 |
318 |
$373K |
| 80053 |
Comprehensive metabolic panel |
63,245 |
50,469 |
$326K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
9,631 |
8,991 |
$293K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,071 |
3,101 |
$257K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
151 |
127 |
$251K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,773 |
2,262 |
$250K |
| 36415 |
Collection of venous blood by venipuncture |
126,122 |
95,672 |
$249K |
| 43450 |
|
1,942 |
1,561 |
$246K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,675 |
5,302 |
$212K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
108 |
63 |
$207K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,209 |
2,746 |
$200K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,223 |
5,374 |
$198K |
| 95811 |
|
88 |
54 |
$178K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,912 |
5,606 |
$177K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,828 |
4,325 |
$167K |
| 80050 |
General health panel |
872 |
817 |
$147K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
465 |
401 |
$144K |
| 64636 |
|
286 |
187 |
$143K |
| 62323 |
|
387 |
280 |
$130K |
| 84484 |
|
18,938 |
13,709 |
$129K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,218 |
4,757 |
$116K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27,570 |
21,510 |
$115K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,198 |
10,020 |
$112K |
| 64494 |
|
365 |
262 |
$97K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
90 |
83 |
$93K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,263 |
1,631 |
$72K |
| 87088 |
|
13,315 |
11,276 |
$71K |
| 80061 |
Lipid panel |
8,363 |
7,602 |
$70K |
| 43235 |
|
73 |
64 |
$65K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,329 |
2,084 |
$65K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,314 |
2,072 |
$64K |
| 99222 |
Initial hospital care, per day, moderate complexity |
108 |
91 |
$63K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,181 |
2,642 |
$60K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
64 |
38 |
$60K |
| 64721 |
|
67 |
45 |
$59K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
237 |
209 |
$52K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
92 |
82 |
$42K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
261 |
233 |
$41K |
| 97605 |
|
307 |
52 |
$38K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,806 |
4,314 |
$38K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,897 |
2,579 |
$37K |
| 86780 |
|
3,547 |
3,164 |
$36K |
| 11045 |
|
282 |
111 |
$34K |
| 93458 |
|
13 |
12 |
$34K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,859 |
1,646 |
$34K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
58 |
52 |
$30K |
| 36475 |
|
22 |
12 |
$29K |
| 81001 |
|
17,024 |
14,018 |
$28K |
| 77336 |
|
235 |
90 |
$28K |
| 86480 |
|
479 |
454 |
$28K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
155 |
136 |
$27K |
| 83690 |
|
8,082 |
6,598 |
$25K |
| 83970 |
|
2,087 |
1,821 |
$23K |
| 80074 |
|
518 |
486 |
$23K |
| 76830 |
Ultrasound, transvaginal |
120 |
106 |
$22K |
| 74018 |
|
205 |
161 |
$21K |
| 29581 |
|
272 |
88 |
$20K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
410 |
303 |
$19K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
94 |
66 |
$19K |
| 45390 |
|
34 |
26 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
947 |
859 |
$16K |
| 82728 |
|
1,860 |
1,656 |
$16K |
| 86850 |
|
3,544 |
3,127 |
$15K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
186 |
129 |
$15K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
526 |
481 |
$15K |
| 86762 |
|
1,329 |
1,150 |
$15K |
| 86803 |
|
1,310 |
1,159 |
$14K |
| 84439 |
|
2,624 |
2,321 |
$14K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
187 |
164 |
$13K |
| 81025 |
|
2,174 |
1,818 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
889 |
305 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,147 |
889 |
$12K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
75 |
55 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
39 |
32 |
$12K |
| 96417 |
|
136 |
62 |
$12K |
| 93017 |
|
111 |
107 |
$11K |
| 87522 |
Neg quan hep c or qual rna |
310 |
281 |
$11K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
13 |
13 |
$11K |
| 94060 |
|
185 |
142 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
267 |
230 |
$9K |
| 76536 |
|
76 |
63 |
$9K |
| 84702 |
|
953 |
593 |
$9K |
| 82607 |
|
978 |
869 |
$9K |
| 83550 |
|
1,752 |
1,508 |
$9K |
| 88346 |
|
19 |
16 |
$9K |
| 87340 |
|
1,279 |
1,110 |
$8K |
| G0378 |
Hospital observation service, per hour |
138 |
68 |
$8K |
| 83880 |
|
474 |
383 |
$8K |
| 83735 |
|
2,646 |
1,730 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,154 |
1,063 |
$8K |
| 71250 |
|
50 |
46 |
$7K |
| 83540 |
|
1,755 |
1,511 |
$7K |
| 82746 |
|
767 |
671 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
134 |
119 |
$6K |
| 84703 |
|
1,084 |
894 |
$6K |
| 64495 |
|
17 |
14 |
$6K |
| 85027 |
|
2,334 |
1,812 |
$6K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
44 |
40 |
$6K |
| 87634 |
|
95 |
84 |
$6K |
| 87081 |
|
778 |
667 |
$5K |
| 84100 |
|
2,546 |
1,719 |
$5K |
| A4649 |
Surgical supply; miscellaneous |
8,609 |
6,978 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,338 |
5,150 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
13 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
29 |
27 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,253 |
1,784 |
$4K |
| 36416 |
|
1,439 |
946 |
$4K |
| 82150 |
|
562 |
523 |
$3K |
| 94762 |
|
23 |
12 |
$3K |
| 86900 |
|
1,382 |
1,193 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
233 |
195 |
$3K |
| 73130 |
|
130 |
122 |
$3K |
| 97035 |
|
24 |
13 |
$3K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
301 |
142 |
$3K |
| 86901 |
|
1,380 |
1,192 |
$3K |
| 96150 |
|
99 |
65 |
$3K |
| 97162 |
|
69 |
57 |
$3K |
| 36591 |
|
42 |
24 |
$3K |
| 87653 |
|
102 |
94 |
$3K |
| 97165 |
|
22 |
13 |
$3K |
| 82947 |
|
898 |
786 |
$2K |
| 86140 |
|
1,113 |
962 |
$2K |
| 82948 |
|
1,380 |
857 |
$2K |
| 83605 |
|
407 |
347 |
$2K |
| 94726 |
|
319 |
239 |
$2K |
| 76775 |
|
63 |
53 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
134 |
120 |
$2K |
| 82248 |
|
464 |
439 |
$2K |
| 97161 |
|
38 |
25 |
$2K |
| 80069 |
|
837 |
680 |
$2K |
| 80076 |
|
447 |
339 |
$2K |
| 83655 |
|
164 |
157 |
$2K |
| 97166 |
|
15 |
12 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
28 |
27 |
$2K |
| 85379 |
|
327 |
262 |
$2K |
| 82570 |
|
620 |
515 |
$1K |
| 73630 |
|
69 |
65 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
30 |
29 |
$1K |
| 93922 |
|
45 |
42 |
$1K |
| 85652 |
|
732 |
645 |
$1K |
| 84460 |
|
409 |
361 |
$1K |
| 96367 |
|
25 |
14 |
$1K |
| 77003 |
|
729 |
598 |
$1K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
54 |
21 |
$998.40 |
| 82565 |
|
335 |
291 |
$978.67 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
27 |
26 |
$959.82 |
| 83615 |
|
441 |
250 |
$947.40 |
| 81003 |
|
741 |
618 |
$933.90 |
| 84156 |
|
560 |
454 |
$885.13 |
| 86200 |
|
129 |
111 |
$827.86 |
| 87510 |
|
47 |
42 |
$815.88 |
| 87480 |
|
47 |
42 |
$815.88 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,307 |
2,726 |
$751.34 |
| 87660 |
|
47 |
42 |
$736.28 |
| 84153 |
|
125 |
111 |
$732.07 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
2,620 |
2,149 |
$727.47 |
| 86038 |
|
121 |
103 |
$712.89 |
| 93971 |
|
26 |
24 |
$697.04 |
| 86225 |
|
100 |
84 |
$686.79 |
| J2704 |
Injection, propofol, 10 mg |
2,664 |
2,069 |
$678.68 |
| 85610 |
|
352 |
298 |
$645.95 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,676 |
1,404 |
$625.34 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12 |
12 |
$583.76 |
| J1453 |
Injection, fosaprepitant, 1 mg |
27 |
14 |
$550.50 |
| 82950 |
|
120 |
115 |
$527.15 |
| 96376 |
|
98 |
39 |
$515.97 |
| 82550 |
|
162 |
138 |
$506.76 |
| 94729 |
|
356 |
261 |
$482.88 |
| 87641 |
|
20 |
14 |
$480.82 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
538 |
441 |
$453.12 |
| 87077 |
|
104 |
79 |
$445.08 |
| 96151 |
|
114 |
37 |
$440.64 |
| 96152 |
|
44 |
27 |
$440.64 |
| 86431 |
|
131 |
113 |
$410.26 |
| 87186 |
|
98 |
76 |
$398.92 |
| 83520 |
|
20 |
17 |
$339.23 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
45 |
38 |
$252.72 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
674 |
539 |
$243.54 |
| 85046 |
|
41 |
41 |
$237.93 |
| J3490 |
Unclassified drugs |
142 |
111 |
$234.37 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
45 |
36 |
$221.62 |
| 82043 |
|
58 |
56 |
$204.77 |
| 86235 |
|
15 |
14 |
$173.79 |
| 84550 |
|
118 |
74 |
$172.99 |
| 88142 |
|
13 |
12 |
$157.08 |
| 85007 |
|
64 |
44 |
$156.69 |
| 83525 |
|
13 |
12 |
$137.16 |
| 82172 |
|
14 |
13 |
$129.16 |
| 82784 |
|
19 |
16 |
$124.69 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
456 |
307 |
$112.77 |
| J2785 |
Injection, regadenoson, 0.1 mg |
13 |
13 |
$94.56 |
| 86704 |
|
17 |
12 |
$82.26 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
622 |
447 |
$55.44 |
| 72202 |
|
13 |
12 |
$54.00 |
| 82962 |
|
68 |
55 |
$33.99 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
28 |
24 |
$27.72 |
| 81596 |
|
14 |
13 |
$17.75 |
| 96373 |
|
16 |
15 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
274 |
197 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
159 |
132 |
$0.00 |
| A9609 |
Fludeoxyglucose f18 up to 15 millicuries |
32 |
28 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
88 |
51 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
37 |
29 |
$0.00 |
| 98961 |
|
12 |
12 |
$0.00 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
1,951 |
1,457 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
65 |
58 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
89 |
55 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
48 |
27 |
$0.00 |
| 88312 |
|
33 |
29 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
231 |
121 |
$0.00 |
| 99152 |
|
25 |
24 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
21 |
12 |
$0.00 |
| 0100U |
|
41 |
30 |
$0.00 |
| C1776 |
Joint device (implantable) |
21 |
15 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
22 |
16 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
16 |
12 |
$0.00 |